CAS: 68076-36-8; Tert-Butyl (4-Aminobutyl)Carbamate

该化合物是一种受保护的矿物衍生物,具有丁基(C4)空间仪和三丁基碳基(Boc)保护组,为原矿提供选择性保护,在多步合成工艺中,特别是在peptide和有机合成中,允许有控制地反应.C4空间仪为同化或进一步功能化提供了灵活性和最佳间隔.该化合物因其在基本条件下的稳定性和在酸性条件下的易脱保性而受到重视,因此适合需要临时防雷保护的应用.其纯度和明确界定的结构确保研究和工业环境中的再生性,以高度精确的方式支持复杂的分子组装.

结构式图片

相似化合物

33545-98-1 14475-60-6 221196-25-4

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号24424-99-5 二碳酸二叔丁酯 | CAS号110-60-1 1,4-丁二胺 | CAS号73371-96-7 2-[[(tert-butox... | CAS号26364-65-8 2-氰基亚胺基-1,3-噻唑烷 | CAS号91419-50-0 Carbamic acid, ... | CAS号33545-97-0 N,N'-二-B°C-1,4-丁二胺 | CAS号129392-85-4 (4-叠氮丁基)氨基甲酸叔丁酯 | CAS号62146-59-2 Z-NH-(CH2)4-NH-B°C | CAS号6627-89-0 叔丁基苯基碳酸酯 | CAS号33545-98-1 B°C-1,4-丁二胺盐酸盐 | CAS号68076-39-1 N1,N5-双-B°C-亚精胺 | CAS号129392-85-4 (4-叠氮丁基)氨基甲酸叔丁酯 | CAS号171856-09-0 Fm°C-N-(4-B°C-氨... | CAS号780802-42-8 [4-(乙基氨基)丁基]氨基甲酸叔丁酯 | CAS号68076-40-4 tert-butyl N-[4... | CAS号99733-14-9 TERT-BUTYL (4-G... | CAS号62146-62-7 N-(苄氧羰基)-1,4-丁二胺 | CAS号404004-37-1 tert-butyl N-[4...

合成工艺路线路线简述

    N,N'-二-Boc-1,4-丁二胺置于甲酸,N,N'-二异丙基碳二亚胺体系中,用 二氯甲烷 作为反应溶剂,化学反应生成 N-叔丁氧羰基-1,4-丁二胺
    参考文献:Improved Synthesis Of 15-Deoxyspergualin Analogs Using The Ugi Multi-Component Reaction
    标题:Improved Synthesis Of 15-Deoxyspergualin Analogs Using The Ugi Multi-Component Reaction
    摘要:Spergualin Is A Natural Product That Exhibits Immunosuppressive,Anti-Tumor And Anti-Bacterial Activities. Its Derivatives,Such As 15-Deoxyspergualin (15-Dsg),Have Been Clinically Approved For Acute Allograft Rejection. However,The Reported Syntheses Are Cumbersome (>10 Steps) And They Suffer From Low Overall Yields (Similar To 0.3% To 18%). Moreover,Spergualin And Its Derivatives Are Chemically Unstable And Rapidly Hydrolyzed In Aqueous Buffer. Here,We Have Re-Explored These Issues And Report A Modified Synthetic Route With Significantly Improved Overall Yield (Similar To 31% To 47%). The Key Transformation Is A Microwave-Accelerated Ugi Multi-Component Reaction That Is Used To Generate The Peptoid Core In A Single Step. Using The Products Of This Route,We Found That Modifications Of The Hemiaminal Significantly Increased Chemical Stability. Thus,We Anticipate That This Synthetic Route Will Improve Access To Biologically Active 15-Dsg Derivatives. (C) 2011 Elsevier Ltd. All Rights Reserved.
    DOI:10.1016/j.Bmcl.2011.02.079

    海关参考信息

    专利信息


    专利号:US-7138526-B1
    优先权日:1999-06-15
    标 题 :Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
    发明人:HERPIN TIMOTHY F; MORTON GEORGE C; SALVINO JOSEPH M
    权利人:AVENTIS PHARMA INC
    摘要:A method for the solid phase synthesis of N,N-disubstituted diazacycloalkylcarboxy derivatives of general formula (I) and (II) is claimed. Examples include piperazine-2-carboxamide. The method is applicable to the synthesis or large combinatorial libraries

    专利号:US-2025129021-A1
    优先权日:2023-09-19
    标 题:Small molecule protein synthesis modulators
    发明人:GYGI DAVID; BAHMANYAR SOGOLE SAMI; HAMANN LAWRENCE
    权利人:INTERDICT BIO INC
    摘要:The present disclosure provides compounds of the formulae herein (e.g., Formula (I), Formula (V)), and pharmaceutically acceptable salts thereof, which are useful for modulating protein synthesis (e.g., modulating synthesis of BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D). The present disclosure also provides pharmaceutical compositions and kits comprising the compounds, or pharmaceutically acceptable salts thereof, and methods of treating or preventing diseases or disorders (e.g., diseases or disorders associated with BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D) by administering to a subject in need thereof the compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof.

    专利号:US-2009099061-A1
    优先权日:2006-01-27
    标 题:Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics
    发明人:FOSS BENTE J; NADOLSKI GEOFFRY T; LOCKWOOD SAMUEL F
    权利人:FOSS BENTE J; NADOLSKI GEOFFRY T; LOCKWOOD SAMUEL F
    摘要:A method is described for synthesizing and administering carotenoid compounds with improved antioxidant characteristics. In some embodiments, extension or improvement of conjugation may be employed in structural modification of carotenoids. In other embodiments, reduction of ring/chain steric hindrance may improve the lambda max, and hence, the overall antioxidant capability, of particular compounds. In other embodiments, introduction and/or increase in synthetic handles for conjugation may improve the stoichiometric ratios of conjugating moieties to the polyene backbone. The methods may be used to improve natural and/or synthetic compounds for medicinal application in the treatment of disease.

    专利号:US-2023219881-A1
    优先权日:2022-01-11
    标题 :Synthesis of Spermidine, Spermine, and Free Bases Thereof
    发明人:TITLOW MATTHEW; GU XINGLONG
    权利人:COMPOUND SOLUTIONS INC; SHAOXING KING YEAR BIOCHEMICAL CO LTD
    摘要:A simplified synthetic process for production of spermine and spermidine are presented that can provide spermine and spermidine in free base or salt form. Advantageously, the synthetic procedure is safe, simple, and environmentally friendly, while at the same time also being cost-effective.

    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    专利号:US-2021299285-A1
    优先权日:2018-07-17
    标题 :Compounds useful for in vivo imaging of protein oxidation and/or cancer treatment
    发明人:FURDUI CRISTINA M; POOLE LESLIE B; KING S BRUCE
    权利人:UNIV WAKE FOREST HEALTH SCIENCES
    摘要:Provided herein are compounds of Formula I, Formula II Formula III which are useful in labeling tissues in a subject (e.g., PET imaging of a subject), for treatment of cancer, and/or for preparing a medicament. Also provided are compounds containing a group that is reactive with sulfenylated proteins for treatment of cancer and/or for preparing a medicament. Methods of synthesis of the compounds and precursor compounds are also provided.
    苏州沃友材料科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.woyouchem.com
    企业联系电话:0512-62560138👤
    📞苏州沃友材料科技有限公司 ⚠️参考联系方式
    联系人:李经理
    电话:0512-62560138


    邮箱:woyousz@163.com
    通信地址: 江苏省苏州工业园区东环路378号
    邮编: 215000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省苏州工业园区东环路378号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    维赛诺化学技术(北京)有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.vscichem.com
    企业联系电话:13811761079👤
    📞维赛诺化学技术(北京)有限公司 ⚠️参考联系方式
    联系人:黎经理
    电话:13811761079
    手机:13811761079

    邮箱:vscichem@163.com
    通信地址: 北京市石景山八大处高科技园区西井路3号3号楼5575房间
    邮编: 102600
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市石景山八大处高科技园区西井路3号3号楼5575房间
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京格林凯默科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chemrocking.com
    电话: 0086(10)6028-1050👤
    📞北京格林凯默科技有限公司 ⚠️参考联系方式

    销售电话:0086(10)6028-1050
    邮箱:chemrocking@bjgreenchem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    重庆艾思摩尔科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.acemol.com
    电话: 023-86822659,👤
    📞重庆艾思摩尔科技有限公司 ⚠️参考联系方式

    销售电话:023-86822659,
    邮箱:sales@acemol.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    连云港尤利特生化科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.unitechemical.com
    企业联系电话:0518-86412158;13705130158👤
    📞连云港尤利特生化科技有限公司 ⚠️参考联系方式
    联系人:陆庆松
    电话:0518-86412158;13705130158
    手机:13705130158
    传真:0518-86400222
    邮箱:sales@unitechemical.com
    通信地址: 江苏省连云港市墩尚镇产业集聚区工业路18号
    邮编: 222037
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省连云港市墩尚镇产业集聚区工业路18号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Jiang F, Et Al.Discovery Of Novel Small Molecule Induced Selective Degradation Of The Bromodomain And Extra-Terminal (Bet) Bromodomain Protein Brd4 And Brd2 With Cellular Potencies.Bioorg Med Chem. 2020 Jan 1;28(1):115181.
    [参考文献]: Hongyan Guo, Et Al. Synthesis And Biological Evaluation Of New Citrate-Based Siderophores As Potential Probes For The Mechanism Of Iron Uptake In Mycobacteria. J Med Chem. 2002 May 9;45(10):2056-63.
    [参考文献]: J Phillip Turner, Et Al. Rationally Designed Peptoids Modulate Aggregation Of Amyloid-Beta 40. Acs Chem Neurosci. 2014 Jul 16;5(7):552-8.
    [参考文献]: L I Kruse, Et Al. Synthesis, Tubulin Binding, Antineoplastic Evaluation, And Structure-Activity Relationship Of Oncodazole Analogues. J Med Chem. 1989 Feb;32(2):409-17.
    [参考文献]: Natalia Karna, Et Al. Peptide Splicing In A Double-Sequence Analogue Of Trypsin Inhibitor Sfti-1 Substituted In The P Positions By Peptoid Monomers. Biopolymers. 2015 May;104(3):206-12.

    合成参考文献


    摘要:Tomás-Gamasa, M., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 2, 14.
    参考文献:10.1007/s11307-019-01365-y
    摘要:Zhang A, Wu T, Bian L, Li P, Liu Q, Zhang D, Jin Q, Zhang J, Huang G, Song S. Synthesis and Evaluation of Ga-68-Labeled Rhein for Early Assessment of Treatment-Induced Tumor Necrosis. Molecular Imaging and Biology. 2019 Jun 27;22(3):515–25. doi: 10.1007/s11307-019-01365-y.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知